AlphaPrime: Using AI to turbocharge clinical trial processes · TechNode
By A Mystery Man Writer
Description
Sharon Chen is the CEO of AlphaPrime, a global health technology company. Prior to founding AlphaPrime, Sharon was the head of Verily China (Alphabet’s
Premier PINC AI™ Data: Three Must-Know Capabilities
Insilico Medicine achieves AI drug discovery breakthrough
Netramark unveils ChatGPT-based trial de-risking technology
KN019-Alphamab Oncology
Two-minute Daily AI Update (Date: 03/05/2024): News from Anthropic, Stability AI, Cloudflare, ChatGPT, Wix, , Groq, and more : r/ArtificialInteligence
Alice Hsu on LinkedIn: AlphaPrime: Using Al to turbocharge clinical trial processes
Sally Ann Frank on LinkedIn: AlphaPrime: Using AI to turbocharge clinical trial processes · TechNode
Antibody Engineering, Antibody Therapeutics
TechNode
from
per adult (price varies by group size)